Mark Gaze Editor

Tom Boterberg graduated as an MD in 1994 at Ghent University. After one year of residency in radiation oncology, he worked for 4 years at the Laboratory of Experimental Cancer Research on the biology of the invasive and metastatic behaviour of breast cancer cells. He obtained his PhD in 2000. Afterwards he continued his training in radiation oncology and in 2001 he obtained his Board Certificate in Radiation Oncology. Since 2001 he works as a staff member at the Department of Radiation Oncology at Ghent University Hospital. He is especially interested in paediatricradiotherapy. He is actively involved in the radiotherapy committees of SIOPEN (neuroblastoma) and EpSSG (rhabdomyosarcoma). He is boardmember of SIOPE and chairs the QUARTET project on quality assurance in paediatric radiotherapy. He is author or co-author of over 100 articlesin peer-reviewed journals. His other interests are haematology, neuro-oncology, intra-operative brachytherapy and radioprotection. Karin Dieckmann graduated from the University of Hamburg,and was trained in Radiology and Radio-oncology at the University of Goettingen and at the Charité Berlin, all in Germany. Since 1994 she has worked at the Department of Radio-oncology of the Medical University Vienna and undertakes research in stereotactic radiosurgery and paediatric radiation oncology. She is especially interested in paediatic radiotherapy and is actively involved in the European Paediatric Hodgkin studies (EuroNetPhL C1 and C2), SIOPEN neuroblastoma study, and the European Brain Tumour Group. For many years she has been a faculty member of the ESTRO teaching courses,and is now chair of the ESTRO paediatric oncology teaching course. She is chair of the German Paediatric Radio-oncology Group (APRO). She is author and co-author of radiation oncology books, and of more than 150 articles in peer-reviewed journals. Mark Gaze qualified from Saint Bartholomew's Hospital, London. He trained in clinical oncology in Edinburgh and Glasgow and undertook research at the universities there. He is a consultant clinical oncologist at University College London Hospitals and Great Ormond Street Hospital for Children NHS Foundation Trusts and has developed a highly specialised practice in paediatric and molecular radiotherapy. He has an interest in both neuroblastoma and rhabdomyosarcoma, and is a member of SIOPEN and EpSSG, chairing their radiotherapy committees in the past, and the National Cancer Research Institute's Neuroblastoma Group. Wider interests in paediatric oncology and medicine in general led him to chair the Children's Cancer and Leukaemia Group, and to have been a member of council for both the Royal College of Physicians of Edinburgh and the Royal College of Radiologists. He is a member of the Administration of Radioactive Substances Advisory Committee for the Department of Health and Social Care.